Another tech titan is partnering with a life sciences company to help patients with a difficult-to-treat disease. This time, Teva Pharmaceutical Industries Ltd. and Santa Clara, Calif.-based Intel are teaming up to develop a wearable device intended to continuously monitor and analyze Huntington's disease symptoms. Read More
